Old West Investment Management LLC Has $3.90 Million Holdings in Theravance Biopharma Inc (TBPH)

Old West Investment Management LLC cut its stake in Theravance Biopharma Inc (NASDAQ:TBPH) by 5.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,942 shares of the biopharmaceutical company’s stock after selling 6,835 shares during the period. Theravance Biopharma accounts for approximately 2.0% of Old West Investment Management LLC’s investment portfolio, making the stock its 21st largest holding. Old West Investment Management LLC owned 0.21% of Theravance Biopharma worth $3,901,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the business. Moneta Group Investment Advisors LLC acquired a new stake in Theravance Biopharma in the third quarter worth $299,000. Schwab Charles Investment Management Inc. increased its position in Theravance Biopharma by 8.0% in the third quarter. Schwab Charles Investment Management Inc. now owns 191,558 shares of the biopharmaceutical company’s stock worth $6,559,000 after buying an additional 14,241 shares during the period. Wells Fargo & Company MN increased its position in Theravance Biopharma by 32.0% in the third quarter. Wells Fargo & Company MN now owns 117,079 shares of the biopharmaceutical company’s stock worth $4,009,000 after buying an additional 28,391 shares during the period. Legal & General Group Plc increased its position in Theravance Biopharma by 15.7% in the third quarter. Legal & General Group Plc now owns 18,840 shares of the biopharmaceutical company’s stock worth $646,000 after buying an additional 2,551 shares during the period. Finally, American International Group Inc. increased its position in Theravance Biopharma by 8.1% in the third quarter. American International Group Inc. now owns 28,000 shares of the biopharmaceutical company’s stock worth $959,000 after buying an additional 2,094 shares during the period. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have weighed in on the company. Cantor Fitzgerald set a $55.00 target price on Theravance Biopharma and gave the stock a “buy” rating in a research report on Wednesday, August 16th. Needham & Company LLC reaffirmed a “buy” rating on shares of Theravance Biopharma in a research report on Tuesday. Evercore ISI assumed coverage on Theravance Biopharma in a research report on Wednesday, August 16th. They issued an “outperform” rating and a $45.00 target price on the stock. ValuEngine lowered Theravance Biopharma from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Finally, Robert W. Baird reissued a “sell” rating and set a $22.00 price target on shares of Theravance Biopharma in a report on Wednesday, November 1st. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $41.86.

Theravance Biopharma Inc (NASDAQ TBPH) opened at $25.82 on Thursday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 7.21 and a current ratio of 7.53. Theravance Biopharma Inc has a fifty-two week low of $23.15 and a fifty-two week high of $43.44.

COPYRIGHT VIOLATION WARNING: “Old West Investment Management LLC Has $3.90 Million Holdings in Theravance Biopharma Inc (TBPH)” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://transcriptdaily.com/2017/12/07/old-west-investment-management-llc-has-3-90-million-holdings-in-theravance-biopharma-inc-tbph.html.

Theravance Biopharma Company Profile

Theravance Biopharma, Inc is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company’s pipeline of internally discovered product candidates includes medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting.

Want to see what other hedge funds are holding TBPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Theravance Biopharma Inc (NASDAQ:TBPH).

Institutional Ownership by Quarter for Theravance Biopharma (NASDAQ:TBPH)

Receive News & Ratings for Theravance Biopharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theravance Biopharma Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply